Keros Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Keros Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2020 to Q3 2024.
Keros Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $19.3M, a 34.7% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$19.3M	+$4.97M	+34.7%	Sep 30, 2024	10-Q	2024-11-06
Q4 2023	$14.4M	+$1.18M	+8.88%	Dec 31, 2023	10-K	2024-02-28
Q3 2023	$14.3M			Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$14M			Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$14M			Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$13.3M	+$12.2M	+1114%	Dec 31, 2022	10-K	2023-03-03
Q4 2021	$1.09M	+$194K	+21.6%	Dec 31, 2021	10-K	2022-03-09
Q3 2021	$1.3M			Sep 30, 2021	10-Q	2021-11-04
Q4 2020	$899K			Dec 31, 2020	10-K	2021-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.